Skip to main content
Watch Insiders
TBPHHealthcare

Theravance Biopharma Inc (TBPH) Insider Trading

In the last 90 days, 1 Theravance Biopharma Inc (TBPH) insider reported no open-market purchases and 1 sale totaling $226,793. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 15, 2026Rhonda FarnumSVP, COMM & MEDICAL AFFAIRSSale13,314$17.03$226,793
Jul 7, 2026Eli SamahaCorporate insiderSale6,964$17.14$119,396
Jul 1, 2026Eli SamahaCorporate insiderSale336,697$17.20$5,791,559
Jun 15, 2026Rhonda FarnumSVP, COMM & MEDICAL AFFAIRSSale13,314$16.39$218,167
Mar 16, 2026Rhonda FarnumSVP, COMM & MEDICAL AFFAIRSSale31,067$13.96$433,636

Common questions

TBPH insider trading FAQ

Are TBPH insiders buying or selling?
Over the last 90 days, TBPH insiders were net sellers, reporting $0.00 of open-market purchases and $226,793 of sales.
When was the last TBPH insider purchase?
No open-market insider purchase of Theravance Biopharma Inc stock was reported in the last 90 days.
Where does TBPH insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Theravance Biopharma Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.